You searched for
We found 9 articles
Benefits of higher oxygen, breathing device persist after infancy
By the time they reached toddlerhood, very preterm infants originally treated with higher oxygen levels continued to show benefits when…
04 Jan 2013
Nasal Application of 5% Tea Tree Oil (TTO) Versus Mupirocin for the Prevention of Catheter-associated Infections in Renal Dialysis Patients
This study will compare the use of tea tree oil against mupirocin as a topical nasal antiseptic to see which…
01 Jan 2013
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma (DREAM)
The purpose of this study is to show whether mepolizumab given every 4 weeks intravenously (i.v.) can reduce the frequency…
01 Jan 2013
Appropriate Oxygen Levels for Extremely Preterm Infants: a Prospective Meta-analysis (NeOProM)
For over 60 years the most appropriate oxygen level for preterm babies remains unknown. To answer this, we will combine…
01 Jan 2013
A Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Prucalopride (Resolor) Tablets in Subjects With Chronic Constipation
The purpose of this study is to compare the efficacy and safety of prucalopride 2 mg given orally once daily…
01 Jan 2013
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
The purpose of this study is to determine if patients with metastatic prostate cancer who have not received chemotherapy live…
01 Jan 2013
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
This is a Phase 2, randomized, double-blind, placebo-controlled multicenter study evaluating the efficacy and safety of two doses of favipiravir…
01 Jan 2013
Randomised, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF (ARTEMIS)
The ARTEMIS-IPF study is for people who have been diagnosed with IPF and are between 40 and 80 years of age. People who have been…
01 Jan 2013
Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma
This is a randomised trial to evaluate the clinical benefit of sorafenib and erlotinib versus sorafenib and placebo in subjects with unresectable advanced or metastatic Child-Pugh A…
01 Jan 2013
